SV Health Investors' Dementia Discovery Fund

SV Health Investors aims to transform healthcare through investments in breakthrough companies and treatments. They support diverse entrepreneurs across three main sectors: Therapeutics, Healthcare Growth, and Medtech. In Therapeutics, they seek innovative breakthroughs with the power to change therapeutic paradigms, especially within the Dementia Discovery Fund (DDF). The Healthcare Growth sector focuses on providing growth capital and liquidity for industry leaders transforming healthcare. The Medtech sector invests in compelling teams and technologies with the power to change medicine. The firm prides itself on providing experienced industry veterans who act as collaborative partners throughout the ventures' life cycle. They focus on building and supporting companies that will improve patients' lives. The Dementia Discovery Fund (DDF), managed by SV Health Investors, specifically targets investments in companies developing innovative solutions for dementia. The fund's strategy is to identify and support novel approaches to treating and preventing dementia, encompassing various therapeutic modalities and stages of development. The DDF emphasizes scientific rigor and collaboration, bringing together leading experts and researchers to accelerate the development of effective treatments for this devastating condition. SV Health Investors also prioritizes diversity and inclusion, believing that diverse teams drive greater success. They are signatories of the Investing in Women Code, reflecting their commitment to supporting talented innovators from all backgrounds. The firm's overall investment approach combines financial capital with deep industry expertise and a collaborative partnership model, aiming to maximize the impact of their investments and improve healthcare outcomes for patients worldwide.

Therapeutics, Healthcare Growth, Medtech, Dementia (via Dementia Discovery Fund)

Core thematic spaces, technologies, and target market segments of interest.